RACHEL SACKNOVITZ: Open Payments
NPI 1790467025 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 79 payments from 14 companies in 2025. Trend: 2023 $180 · 2024 $548 · 2025 $1,325
Food & beverage: $1,065Education: $260
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $305 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $248 |
| ABBVIE INC. | 12 | $185 |
| Novartis Pharmaceuticals Corporation | 6 | $124 |
| Botanix SB Inc | 5 | $105 |
| Arcutis Biotherapeutics, Inc. | 5 | $89 |
| Amgen Inc. | 4 | $75 |
| Galderma Laboratories, L.P. | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| UCB, Inc. | 2 | $28 |
Products named: TREMFYA, SKYRIZI, ILUMYA, COSENTYX, SOFDRA, Zoryve, OTEZLA, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
